Greene John — SEC Form 4 filings
SEC reporting owner CIK 1610732. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-09.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-30 to 2026-06-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 7,000 shares, $313,948 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 35,191 shares, $3,748,193 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 35,191 shares @ $106.51 ($3,748,193) in Discover Financial Services, filed 2024-01-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Discover Financial Services (DFS) | EVP, Chief Financial Officer | 8 | — | 1 leg · 35,191 sh · $3,748,193 | 11 |
| CRISPR Therapeutics AG (CRSP) | Director | 4 | 1 leg · 7,000 sh · $313,948 | — | 3 |
| NORTHROP GRUMMAN CORP /DE/ (NOC) | CVP & Chief Financial Officer | 1 | — | — | 2 |
Form 4 filings — Greene John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-09 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Grant/award (A): 4,981 (derivative) @ $0 · Grant/award (A): 5,362 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Discover Financial Services (DFS) | Disposition to issuer (D): 79,943 | EDGAR |
| 2025-02-28 | 4 | CRISPR Therapeutics AG (CRSP) | Purchase (P): 7,000 @ $44.85 | EDGAR |
| 2025-02-04 | 4 | Discover Financial Services (DFS) | Tax withholding (F): 1,840 @ $201.09 | EDGAR |
| 2025-01-27 | 4 | Discover Financial Services (DFS) | Grant/award (A): 14,630 @ $0 | EDGAR |
| 2024-12-23 | 4 | Discover Financial Services (DFS) | Grant/award (A): 12,109 @ $0 · Tax withholding (F): 11,702 @ $169.27 | EDGAR |
| 2024-05-31 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | Discover Financial Services (DFS) | Grant/award (A): 29,324 @ $0 · Grant/award (A): 9,051 @ $0 | EDGAR |
| 2024-02-05 | 4 | Discover Financial Services (DFS) | Grant/award (A): 21,801 @ $0 · Tax withholding (F): 12,290 @ $106.56 | EDGAR |
| 2024-02-05 | 4 | Discover Financial Services (DFS) | Grant/award (A): 21,801 @ $0 · Tax withholding (F): 12,290 @ $106.56 | EDGAR |
| 2024-01-30 | 4 | Discover Financial Services (DFS) | Sale (S): 35,191 @ $106.51 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1610732 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →